Building on these observations, when the biomarkers were analyzed separately by amyloid status and correlation analysis was performed between eGFR and plasma biomarkers, the significance disappeared for the Aβ42/40 ratio, p-tau species, and GFAP in Aβ-positive cases. The gene discussed is GFAP; the disease is amyloidosis.